8. Cho, T. M.; Hasegaua, J.; Ge, B. L.; Loh, H. H. Purification to
homogeneity of a mu-type of opioid receptor from rat brain.
Proc. Natl. Acad. Sci. USA. 83:4138 – 4142; 1986. 25.
9. Comer, S. D.; Burke, T. F.; Lewis, J. W.; Woods, J. H.
Clocinnamox: a novel, systemically-active, irreversible opioid
antagonist. J. Pharmacol. Exp. Ther. 262:1051–1056; 1992.
10. Dooley, C. T.; Chung, N. N.; Wilkes, B. C.; Schiller, P. W.;
Bidlack, J. M.; Pasternak, G. W.; Houghten, R. A. An all 26.
D-amino acid opioid peptide with central analgesic activity
from a combinatorial library. Science (Washington DC). 266:
2019 –2022; 1994.
11. Evans, C. J.; Keith, D. E., Jr.; Morrison, H.; Magendzo, K.;
Edwards, R. H. Cloning of a delta opioid receptor by func- 27.
tional expression. Science (Washington DC). 258:1952–1955;
1992.
12. Gioannini, T. L.; Howard, A. D.; Hiller, J. M.; Simon, E. J. 28.
Purification of an active opioid binding protein from bovine
striatum. J. Biol. Chem. 260:15117–15121; 1985.
13. Jiang, Q.; Takemori, A. E.; Sultana, M.; Portoghese, P. S.;
Bowen, W. D.; Mosberg, H. I.; Porreca, F. Differential antag- 29.
onism of opioid delta antinociception by enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257:1069 –1075; 1991. 30.
14. Kieffer, B. L.; Befort, K.; Gaveriaux-Ruff, C.; Hirth, C. G.
The d-opioid receptor: isolation of a cDNA by expression
cloning and pharmacological characterization. Proc. Natl. 31.
Acad. Sci. USA. 89:12048 –12052; 1992.
15. Kim, C.-H.; Rothman, R. B.; Jacobson, A. E.; Mattson, M. V.;
Bykov, V.; Streaty, R. A.; Klee, W. A.; George, C.; Long, 32.
J. B.; Rice, K. C. Probes for narcotic receptor mediated
phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta
opioid receptors in vitro. J. Med. Chem. 32:1392–1398; 1989. 33.
16. Knott, G. D.; Reece, D. K. MLAB: a civilized curve fitting
system. Proceedings of the Online 1972 International Conference 1:497–526; 1972.
17. Kosterlitz, H. W.; Paterson, S. J.; Robson, L. E. Characterization of the kappa-subtype of the opiate receptor in the guinea
pig brain. Br. J. Pharmacol. 73:939 –949; 1981. 34.
18. Lai, J.; Bilsky, E. J.; Rothman, R. B.; Porreca, F. Treatment
with antisense oligodeoxynucleotide to the opioid d receptor
inhibits d -agonist antinociception. Neuroreport.
2

5:1049 –1052; 1994.
19. Lord, J. A.; Waterfield, A.; Hughes, J.; Kosterlitz, H. W.
Endogenous opioid peptides: multiple agonists and receptors. 35.
Nature (London). 267:495– 499; 1977.
20. Mattia, A.; Farmer, S. C.; Takemori, A. E.; Sultana, M.;
Portoghese, P. S.; Mosberg, H. I.; Bowen, W. D.; Porreca, F.
Spinal opioid delta antinociception in the mouse: mediation by 36.
a 5'-NTII-sensitive delta receptor subtype. J. Pharmacol. Exp.
Ther. 260:518 –525; 1992.
21. Mattia, A.; Vanderah, T.; Mosberg, H. I.; Porreca, F. Lack of
antinociceptive cross-tolerance between enkephalin and deltorphin II in mice: evidence for delta receptor subtypes.
J. Pharmacol. Exp.Ther. 258:583–587; 1991. 37.
22. McGonigle, P.; Neve, K. A.; Molinoff, P. B. A quantitative
method of analyzing the interaction of slightly selective ra- dioligands with multiple receptor subtypes. Mol. Pharmacol.
30:329 –337; 1986.
23. Mosberg, H. I.; Hurst, R.; Hruby, V. J.; Gee, K.; Yamamura, 38.
H. I.; Galligan, J. J.; Burkes, T. F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid
receptors. Proc. Natl. Acad. Sci. USA. 80:5871–5874; 1983.
24. Munson, P. J.; Rodbard, D. LIGAND: a versatile computer- 39.
